552
Views
0
CrossRef citations to date
0
Altmetric
Portrait

From vaccines to global health to vaccines

References

  • Kieny MP, Lathe R, Drillien R, Spehner D, Skory S, Schmitt D, Wiktor T, Koprowski H, Lecocq JP. Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature. 1984 Nov 8- 14;312(5990):163–166. PubMed PMID: 6548799.
  • Pastoret PP, Brochier B, Languet B, Thomas I, Paquot A, Bauduin B, Kieny MP, Lecocq JP, De Bruyn J, Costy F, et al. First field trial of fox vaccination against rabies using a vaccinia-rabies recombinant virus. Vet Rec. 1988 Nov 5;123(19):481–483. PubMed PMID: 3201693.
  • Kieny MP, Lathe R, Rivière Y, Dott K, Schmitt D, Girard M, Montagnier L, Lecocq J. Improved antigenicity of the HIV env protein by cleavage site removal. Protein Eng. 1988 Sep;2(3):219–225. PubMed PMID: 3237686.
  • Gilbert PB1, Berger JO, Stablein D, Becker S, Essex M, Hammer SM, Kim JH, Degruttola VG. SStatistical interpretation of the RV144 HIV vaccine efficacy trial in Thailand: a case study for statistical issues in efficacy trials. J Infect Dis. 2011 Apr 1;203(7):969–975. doi: 10.1093/infdis/jiq152.
  • LaForce FM, Djingarey M, Viviani S, Preziosi MP. Successful African introduction of a new group A meningococcal conjugate vaccine: future challenges and next steps. Hum Vaccin Immunother. 2018 May 4;14(5):1098–1102. doi: 10.1080/21645515.2017.1378841. Epub 2017 Nov 8. PMID: 28968148.
  • Friede M, Palkonyay L, Alfonso C, Pervikov Y, Torelli G, Wood D, Kieny MP. WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer. Vaccine. 2011 Jul 1;29(Suppl 1):A2–7. doi: 10.1016/j.vaccine.2011.02.079. PMID: 21684422.
  • Henao-Restrepo AM, Camacho A, Longini IM, Watson CH, Edmunds WJ, Egger M, Carroll MW, Dean NE, Diatta I, Doumbia M, et al. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). Lancet. 2017 Feb 4;389(10068):505–518. doi: 10.1016/S0140-6736(16)32621-6. Epub 2016 Dec 23. Erratum in: Lancet. 2017 Feb 4;389(10068):504.Lancet. 2017 Feb 4;389(10068):504.PMID: 28017403.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.